An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
An interview with Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
-
Narrated by:
-
By:
About this listen
In this episode, we interview Sarah Emond, MPP, President and CEO of the Institute for Clinical and Economic Review (ICER). Sarah joined ICER over 15 years ago as Chief Operating Officer and was appointed to lead the organization following the retirement of Dr. Steven Pearson. Sarah outlines her vision for ICER and the priorities for strengthening the framework and collaboration to achieve their mission of evaluating the comparative effectiveness of new medicines. Sarah also discusses ICER’s efforts to expand patient engagement and the evaluation of payers to ensure fair access to medicine.
- Sarah Emond, MPP, President and CEO, Institute for Clinical Economic Review (ICER)
- Dr. Steven Pearson, Founder, President, Institute for Clinical and Economic Review (ICER)
- Barriers to Fair Access Report
- Gross-to-Net Bubble
- Pharmacy Benefit Managers (PBMs)
- Humira biosimilars
- Institute for Clinical and Economic Review (ICER)
-
340B Drug Pricing Program
Questions or comments?
Email us at comments@prescriptionforbetteraccess.com.
Find us on social media! Follow us on X, LinkedIn, YouTube and Threads.
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet